Cargando…
SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma
Migration and invasion play crucial roles in the progression of hepatocellular carcinoma (HCC), but the underlying mechanisms are not clear. Analysis of clinical samples indicates that SQSTM1/p62 is highly expressed in HCC and seriously affects the prognosis of patients. Subsequently, we showed that...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177541/ https://www.ncbi.nlm.nih.gov/pubmed/37174639 http://dx.doi.org/10.3390/cells12091238 |
_version_ | 1785040662742171648 |
---|---|
author | Lu, Jinghua Ding, Yipei Zhang, Wanqiu Qi, Yuanyuan Zhou, Jin Xu, Naihan Zhang, Yaou Xie, Weidong |
author_facet | Lu, Jinghua Ding, Yipei Zhang, Wanqiu Qi, Yuanyuan Zhou, Jin Xu, Naihan Zhang, Yaou Xie, Weidong |
author_sort | Lu, Jinghua |
collection | PubMed |
description | Migration and invasion play crucial roles in the progression of hepatocellular carcinoma (HCC), but the underlying mechanisms are not clear. Analysis of clinical samples indicates that SQSTM1/p62 is highly expressed in HCC and seriously affects the prognosis of patients. Subsequently, we showed that SQSTM1/p62 knockout using the CRISPR/Cas9 system led to impaired migration and invasion of HCC, upregulated Keap1, and promoted the inhibitory effect of Keap1 on Nrf2. Then, the inactivation of Nrf2 inhibited the expression of matrix metalloproteinases (MMPs), thus attenuating the migration and invasion of HCC. We also found that SQSTM1/p62 knockout significantly inhibited migration and invasion in a lung metastasis model of nude mice with HCC. Furthermore, we found that cisplatin not only significantly inhibited the expression of SQSTM1/p62 but also slowed down the migration and invasion of HCC, while the inflammatory microenvironment accelerated the migration and invasion of HCC. These results suggest for the first time that SQSTM1/p62 knockout inhibits the migration and invasion of HCC through the Keap1/Nrf2/MMP2 signaling pathway. SQSTM1/p62 may be developed into a key drug target to regulate the migration and invasion of HCC cells. |
format | Online Article Text |
id | pubmed-10177541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101775412023-05-13 SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma Lu, Jinghua Ding, Yipei Zhang, Wanqiu Qi, Yuanyuan Zhou, Jin Xu, Naihan Zhang, Yaou Xie, Weidong Cells Article Migration and invasion play crucial roles in the progression of hepatocellular carcinoma (HCC), but the underlying mechanisms are not clear. Analysis of clinical samples indicates that SQSTM1/p62 is highly expressed in HCC and seriously affects the prognosis of patients. Subsequently, we showed that SQSTM1/p62 knockout using the CRISPR/Cas9 system led to impaired migration and invasion of HCC, upregulated Keap1, and promoted the inhibitory effect of Keap1 on Nrf2. Then, the inactivation of Nrf2 inhibited the expression of matrix metalloproteinases (MMPs), thus attenuating the migration and invasion of HCC. We also found that SQSTM1/p62 knockout significantly inhibited migration and invasion in a lung metastasis model of nude mice with HCC. Furthermore, we found that cisplatin not only significantly inhibited the expression of SQSTM1/p62 but also slowed down the migration and invasion of HCC, while the inflammatory microenvironment accelerated the migration and invasion of HCC. These results suggest for the first time that SQSTM1/p62 knockout inhibits the migration and invasion of HCC through the Keap1/Nrf2/MMP2 signaling pathway. SQSTM1/p62 may be developed into a key drug target to regulate the migration and invasion of HCC cells. MDPI 2023-04-25 /pmc/articles/PMC10177541/ /pubmed/37174639 http://dx.doi.org/10.3390/cells12091238 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Jinghua Ding, Yipei Zhang, Wanqiu Qi, Yuanyuan Zhou, Jin Xu, Naihan Zhang, Yaou Xie, Weidong SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title | SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title_full | SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title_fullStr | SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title_full_unstemmed | SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title_short | SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma |
title_sort | sqstm1/p62 knockout by using the crispr/cas9 system inhibits migration and invasion of hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177541/ https://www.ncbi.nlm.nih.gov/pubmed/37174639 http://dx.doi.org/10.3390/cells12091238 |
work_keys_str_mv | AT lujinghua sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT dingyipei sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT zhangwanqiu sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT qiyuanyuan sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT zhoujin sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT xunaihan sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT zhangyaou sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma AT xieweidong sqstm1p62knockoutbyusingthecrisprcas9systeminhibitsmigrationandinvasionofhepatocellularcarcinoma |